Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-09-09 17:52:14 ET · period of report 2026-09-08 · accession 0001960048-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-09 17:52 | 2026-09-08 | PCVX | Cowan Elvia | SVP, CAO, Fin | F - Tax | $60.36 | -1,327 | 27.9K | -5% | -$80.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-08 | F | D | 1,327 | $60.36 | 27,860 | D | — | — | (F1) Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. |